Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Italiano

Showing results (141-150 of 418) with videos related to

Pageof 42
Sort By:
Cancer|June 1, 2012
Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomicsAntoine Italiano, Chun-Liang Chen, Rachael Thomas, et al.
Diagnostic and Interventional Imaging|February 14, 2026
Beyond handcrafted radiomics in oncologic imaging: Innovations in deep, explainable, multi-site and multi-omics radiomics approachesJules Dupont, Fiona Frau, Victor Robic, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapyLydia Lartigue, Agnès Neuville, Pauline Lagarde, et al.
JCO Precision Oncology|September 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of CareCarsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas, et al.
Cancer|October 15, 2010
Trends in survival for patients with metastatic soft-tissue sarcomaAntoine Italiano, Simone Mathoulin-Pelissier, Axel Le Cesne, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2013
Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13Jean-Baptiste Bachet, Bruno Landi, Pierre Laurent-Puig, et al.
Acta Oncologica (Stockholm, Sweden)|April 28, 2022
Exploratory analysis of tumor imaging in a Phase 2 trial with cabozantinib in gastrointestinal stromal tumor: lessons learned from study EORTC STBSG 1317 'CaboGIST'Anastasios Kyriazoglou, Pieter Jespers, Vincent Vandecavaye, et al.
Thyroid : Official Journal of the American Thyroid Association|June 6, 2013
Brain metastases from thyroid carcinoma: a retrospective study of 21 patientsBénédicte Henriques de Figueiredo, Yann Godbert, Isabelle Soubeyran, et al.
Biomarker Research|January 7, 2024
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS studyAmandine Crombé, Frédéric Bertolo, Lucile Vanhersecke, et al.
The Oncologist|April 14, 2018
Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group TrialsEugenie Younger, Saskia Litière, Axel Le Cesne, et al.
Pageof 42

Showing results (141-150 of 418) with videos related to

Sort By:
Pageof 42
Cancer|June 1, 2012
Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomicsAntoine Italiano, Chun-Liang Chen, Rachael Thomas, et al.
Diagnostic and Interventional Imaging|February 14, 2026
Beyond handcrafted radiomics in oncologic imaging: Innovations in deep, explainable, multi-site and multi-omics radiomics approachesJules Dupont, Fiona Frau, Victor Robic, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapyLydia Lartigue, Agnès Neuville, Pauline Lagarde, et al.
JCO Precision Oncology|September 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of CareCarsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas, et al.
Cancer|October 15, 2010
Trends in survival for patients with metastatic soft-tissue sarcomaAntoine Italiano, Simone Mathoulin-Pelissier, Axel Le Cesne, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2013
Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13Jean-Baptiste Bachet, Bruno Landi, Pierre Laurent-Puig, et al.
Acta Oncologica (Stockholm, Sweden)|April 28, 2022
Exploratory analysis of tumor imaging in a Phase 2 trial with cabozantinib in gastrointestinal stromal tumor: lessons learned from study EORTC STBSG 1317 'CaboGIST'Anastasios Kyriazoglou, Pieter Jespers, Vincent Vandecavaye, et al.
Thyroid : Official Journal of the American Thyroid Association|June 6, 2013
Brain metastases from thyroid carcinoma: a retrospective study of 21 patientsBénédicte Henriques de Figueiredo, Yann Godbert, Isabelle Soubeyran, et al.
Biomarker Research|January 7, 2024
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS studyAmandine Crombé, Frédéric Bertolo, Lucile Vanhersecke, et al.
The Oncologist|April 14, 2018
Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group TrialsEugenie Younger, Saskia Litière, Axel Le Cesne, et al.
Pageof 42